Archer® FusionPlex® Solid Tumor Kit is a robust targeted sequencing assay to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas.
Studies are performed from RNA extracted from several types of samples (fresh frozen or FFPE). Using Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment, fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.
Archer Analysis software allows the analysis and interpretation of the data.
|AB0005 — 8 reactions|
|AB0057 — 48 reactions|